Compare Imorgon vs. Oncoustics

Improve radiology reporting efficiency and report quality with Imorgon's reporting automation. As the top DICOM SR software for radiology, our solution significantly reduces unnecessary dictation by precisely transferring ultrasound and DEXA modality measurements into Powerscribe, Fluency, or RadAI. This eliminates manual errors and significantly accelerates the generation of reports. Imorgon's unique advantages include: - guaranteed transfer of all measurements - usually DICOM SR - electronic worksheets for direct report population (eliminating dictation from notes) - worksheets with priors, calculators, and clinical decision support (TI-RADS, O-RADS, etc) - integration with Epic and other EHRs. - vendor-neutral Our dedicated support team ensures uninterrupted workflow. Invest in Imorgon for a quick and substantial return on investment, transforming your reporting overhead into a streamlined, high-quality operation.

Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.